Pregnancy complications and obstetric care in women with inherited bleeding disorders

Haemophilia

Volumn 19, Issue SUPPL.4, 2013, Pages 1-10

  Kadir, R A ^a   Davies, J ^a   Winikoff, R ^b   Pollard, D ^a   Peyvandi, F ^c   Garagiola, I ^c   Pabinger, I ^d   Federici, A B ^e  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre   (Italy)

^d Division of Haematology and Blood Coagulation   (Austria)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Haemophilia; Labour; Multidisciplinary team; Pregnancy; Prenatal diagnosis

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

AMNIOCENTESIS; ANTEPARTUM HEMORRHAGE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CHORION VILLUS SAMPLING; CORDOCENTESIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; FIBRINOGEN DEFECT; FIBRINOLYTIC THERAPY; FINE NEEDLE ASPIRATION BIOPSY; FLUSHING; HEMOPHILIA A; HEMOPHILIA B; HORMONAL THERAPY; HUMAN; LABOR MANAGEMENT; NAUSEA; NONHUMAN; OBSTETRIC PROCEDURE; OPERATIVE BLOOD LOSS; POSTPARTUM HEMORRHAGE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS CONTRACTION; VON WILLEBRAND DISEASE;

HAEMOPHILIA; LABOUR; MULTIDISCIPLINARY TEAM; PREGNANCY; PRENATAL DIAGNOSIS;

BLOOD COAGULATION DISORDERS, INHERITED; DELIVERY OF HEALTH CARE; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; OBSTETRIC NURSING; PATIENT CARE MANAGEMENT; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL DIAGNOSIS;

EID: 84885234367     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12269     Document Type: Review

References (49)

1. A national service specification for haemophilia and other inherited bleeding disorders Available at http://www.ukhcdo.org/docs/HaemAlliance-NatSvsSpec2006.pdf6, The Haemophilia Alliance. Accessed February 2006.
2. Carbonell-Baeza A, Aparicio VA, Chillion P, Fernia P, Delgado-Fernandez M, Ruiz JR. Effectiveness of multidisciplinary therapy on symptomatology and quality of life in women with fibromyalgia. Clin Exp Rheumatol 2011; 29(6 Suppl. 69): S97-103.
3. Brandow AM, Weisman SJ, Panepinto JA. The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. Pediatr Blood Cancer 2011; 56: 789-93.
4. Wijeysundera HC et al. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Value Health 2010; 13: 915-21.
5. WHO. Women's Health: Today's evidence Tomorrow's Agenda, Geneva: World Health Organisation, 2009.
6. Winikoff R, Armesse C, James A, Lee C, Pollard D. The role of haemophilia treatment centres in providing services to women with bleeding disorders. Haemophilia 2004; 10(Suppl.4): 196-204.
7. Kadir RA, Sharief LA, Lee CA. Inherited bleeding disorders in older women. Maturitas 2012; 72: 35-41.
8. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
9. Lee CA et al. The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006; 12: 301-36.
10. Khair K. Supporting adherence and improving quality of life in haemophilia care. Brit J Nurs 2013; 22: 692.
11. Renault NK, Howell RE, Robinson KS, Greer WL. Qualitative assessment of the emotional and behavioural responses of haemophilia A carriers to negative experiences in their medical care. Haemophilia 2011; 17: 237-45.
12. Chi C, Hyett JA, Finning KM, Lee CA, Kadir RA. Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia. BJOG 2006; 113: 239-42.
13. Balak DM et al. Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the Netherlands. Haemophilia 2012; 18: 584-92.
14. Meagher S, Davison G. Early second-trimester determination of fetal gender by ultrasound. Ultrasound Obstet Gynecol 1996; 8: 322-4.
15. Chi C. Antenatal diagnosis. In: Lee CA, Kadir RA, Kouides PA eds. Inherited Bleeding Disorders in Women. Chichester: Blackwell Publishing Ltd, 2009: 99-123.
16. Alfirevic Z, Walkinshaw SA, Kilby MD. Green-top Guideline No. 8. Amniocentesis and Chorionic Villus Sampling, RCOG, Editor 2010, London: Royal College of Obstetrics and Gynaecologists.
17. Gordon MC, Narula K, O'Shaughnessy R, Barth WH Jr. Complications of third-trimester amniocentesis using continuous ultrasound guidance. Obstet Gynecol 2002; 99: 255-9.
18. Tsui NB et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684-91.
19. Tuddenham EG. Genetic and laboratory diagnosis. In: Lee CA, Kadir RA, Kouides PA eds. Inherited Bleeding Disorders in Women. Chichester: Blackwell Publishing Ltd, 2009: 90-8.
20. Fiorentino F et al. The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders. Mol Hum Reprod 2003; 9: 399-410.
21. Sinha P, Kuruba N. Ante-partum haemorrhage: an update. J Obstet Gynaecol 2008; 28: 377-81.
22. Kumar M, Mehta P. Congenital coagulopathies and pregnancy: report of four pregnancies in a factor X-deficient woman. Am J Hematol 1994; 46: 241-4.
23. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003; 1: 1852-3.
24. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 2003; 29: 171-4.
25. Girolami A, Randi ML, Ruzzon E, Lombardi AM, Girolami B, Fabris F. Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. Acta Haematol 2006; 115: 58-63.
26. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165-9.
27. Siboni SM et al. Gynaecological and obstetrical problems in women with different bleeding disorders. Haemophilia 2009; 15: 1291-9.
28. Iwaki T, Sandoval-Cooper MJ, Paiva M, Kobayashi T, Ploplis VA, Castellino FJ. Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 2002; 160: 1021-34.
29. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102: 4410-12.
30. Souri M, Koseki-Kuno S, Takeda N, Degen JL, Ichinose A. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol 2008; 87: 60-8.
31. Peyvandi F, Bidlingmaier C, Garagiola I. Management of pregnancy and delivery in women with inherited bleeding disorders. Semin Fetal Neonatal Med 2011; 16: 311-17.
32. Huq FY, Kadir RA. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia 2011; 17(Suppl.1): 20-30.
33. Chi C, Lee CA, England A, Hingorani J, Paintsil J, Kadir RA. Obstetric analgesia and anaesthesia in women with inherited bleeding disorders. Thromb Haemost 2009; 101: 1104-11.
34. Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med 1999; 341: 1709-14.
35. Kulkarni R et al. Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia 2009; 15: 1281-90.
36. Hogan MC et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010; 375: 1609-23.
37. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008; 115: 1265-72.
38. Chauleur C et al. Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost 2008; 6: 2067-74.
39. Peitsidis P, Kadir RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother 2011; 12: 503-16.
40. Phillips LE et al. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg 2009; 109: 1908-15.
41. Alfirevic Z et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. Obstet Gynecol 2007; 110: 1270-8.
42. Meybohm P, Herrmann E, Nierhoff J, Zacharowksi K. Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and epsilon-aminocaproic acid - a meta-analysis of randomised and observational trials of over 30.000 patients. PLoS ONE 2013; 8: e58009.
43. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009; 9: 29.
44. Ducloy-Bouthors AS et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117.
45. Shakur H et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.
46. Federici AB. The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007). Haemophilia 2008. 14(Suppl. 1): 5-14.
47. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. New Eng J Med 1983; 309: 816-21.
48. Seary ME, Feldman D, Carcao MD. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype. Haemophilia 2012. 18: 50-5.
49. Trigg DE, Sterigiotou I, Peitsidis P, Kadir RA. A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 2012; 18: 25-33.